BABA Quantitative Stock Analysis

Validea's guru fundamental report indicates Alibaba (BABA) scores 80% using the Kenneth Fisher Price/Sales Investor model, signaling 'some interest' from this value strategy. The large-cap growth stock is favored for its low Price/Sales ratio, strong free cash flow, and consistent profit margins, despite a noted weakness in long-term EPS growth. This assessment suggests BABA's current valuation and financial health align with a quantitative value investing approach focused on sales and cash flow.

Analysis

Alibaba Group Holding Ltd. (BABA) scores an 80% rating according to Validea's Price/Sales Investor model, which is based on Kenneth Fisher's value-oriented strategy. This score indicates a moderate level of interest, primarily driven by the company's performance on key value metrics. The analysis shows BABA passes criteria for its total debt-to-equity ratio, free cash per share, and three-year average net profit margin, suggesting a healthy balance sheet and consistent profitability. However, the report flags significant weaknesses, as the company fails tests for its long-term EPS growth rate. Notably, the underlying data presents a contradiction, listing the price-to-sales ratio as both a 'PASS' and a 'FAIL', creating ambiguity around the core metric of the very model being used. This positions BABA as a stock with an attractive valuation from a sales and cash flow perspective but with a concerning outlook for future earnings growth.

Key Decisions for Investors

• Value-focused investors may find BABA's profile attractive due to its strong free cash flow and favorable debt-to-equity ratio, but should weigh this against the flagged weakness in long-term earnings growth.
• Growth-oriented investors should exercise caution, as the explicit failure on the long-term EPS growth rate metric signals a potential misalignment with strategies that prioritize accelerating earnings.
• Given the report's contradictory signals on the price-to-sales ratio, it is prudent to conduct further due diligence to validate the company's valuation against its sales before committing capital.